César Magro‐Checa

Author

César Magro‐Checa

Also Known As

C Magro, C Magro-Checa, C. Magro, C. Magro Checa, C. Magro-Checa, C. Magro‐Checa, Carla da Silva Magro, Cesar Magro, Cesar Magro Checa, Cesar Magro-Checa

113

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Instituto de Investigación Biosanitaria de Granada Instituto de Parasitología y Biomedicina "López - Neyra"Zuyderland Medisch Centrum Bellvitge University Hospital

About

César Magro‐Checa is an author at Leiden University Medical Center specializing in medicine, rheumatology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	362
2	Public Health	2	2	37
3	Health Sciences	1	1	30
4	Social Sciences	1	1	45
5	Allergy	1	1	34

César Magro‐Checa

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study Sofía Ramiro, Rémy L.M. Mostard, César Magro‐Checa, Annals of the Rheumatic Diseases	2020	231
A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility F. David Carmona, Sarah Mackie, Jose‐Ezequiel Martín, The American Journal of Human Genetics	2015	174
Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites Ece Ercan, César Magro‐Checa, Romain Valabrègue, Brain	2016	78
Value of multidisciplinary reassessment in attribution of neuropsychiatric events to systemic lupus erythematosus: prospective data from the Leiden NPSLE cohort César Magro‐Checa, E. Zirkzee, Liesbeth J J Beaart-van de Voorde, Lara D. Veeken	2017	63
A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus Ece Ercan, Carson Ingo, Oranan Tritanon, NeuroImage Clinical	2015	55
C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus Rosanne A. van Schaarenburg, César Magro‐Checa, Jaap Bakker, Frontiers in Immunology C1q GenesImmunologyPathologyHematologyAutoantibodies	2016	50
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis Aida Ferreiro-Iglesias, Ariana Montes, Eva Pérez‐Pampín, The Pharmacogenomics Journal InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseMedicine	2015	47
Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts Michael Ziegelasch, Myrthe A. M. van Delft, Philip Wallin, Arthritis Research & Therapy	2016	47
Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer Remy J.H. Martens, Arjan J. van Adrichem, Nadine J.A. Mattheij, Clinical Chemistry and Laboratory Medicine (CCLM)	2020	46
Neuropsychiatric symptoms in systemic lupus erythematosus: impact on quality of life Rory C. Monahan, Liesbeth J J Beaart-van de Voorde, Gerda M. Steup‐Beekman, Lupus Quality Of LifeLife AssessmentNeuropsychologyNeuropsychiatryNeuropsychiatric Symptoms	2017	45

Page 1